Clinical Trial

Registry Platform Urologic Cancer

Study acronym: CARAT
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced renal cell carcinoma or urothelial cancer in Germany.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-12-12; most recent amendment 2026-07-10.
Trial Details
NCT Number NCT03374267
Lead Sponsor iOMEDICO AG
Conditions Renal Cell Carcinoma, Urothelial Carcinoma
Enrollment 2,230 participants
Start Date 2017-12-07
Primary Completion 2034-03 (estimated)
Study Completion 2034-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-14